Market News AIOpen the app

RLMD stock news · Relmada Therapeutics

Stories about Relmada Therapeutics (RLMD) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for RLMD

Follow Relmada Therapeutics (RLMD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RLMD
Free on the App Store and Google Play, or on the web.
  1. Oct 12, 2026, 7:27 AM ET · Results

    Relmada Therapeutics shares details from its earnings call for the second quarter of 2026.

    Good for RLMD

    Relmada's 12-month study results showed 95% of patients had a complete response at some point. Cash through 2029 supports a positive outlook, though production work remains.

  2. Sep 29, 2026, 5:22 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Tuesday.

    Neutral

    The article reports Relmada Therapeutics shares rose 5%, but gives no company news behind the move. It does not change the business outlook.